Skip to content
DraconiticResearch
Search Sources API
197,785 studies31 sourcesUpdated 7 min ago
Peer-reviewedCC BY-NC-NDCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

Utilisation du lecanemab au stade précoce de la maladie d’Alzheimer au Canada.

  • Sophie M Weiss1
  • Jennifer A Watt1
  • Vivian Ewa1
  • Sharon E Straus2
  1. 1Département de médecine (Weiss, Watt, Straus), Temerty Faculty of Medicine, University of Toronto; Unity Health Toronto (Watt, Straus); Li Ka Shing Knowledge Institute (Watt, Straus), St. Michael's Hospital, Toronto, Ont.; Département de médecine familiale (Ewa), University of Calgary; Assisted Living Alberta (Ewa), Calgary, Alb.
  2. 2Département de médecine (Weiss, Watt, Straus), Temerty Faculty of Medicine, University of Toronto; Unity Health Toronto (Watt, Straus); Li Ka Shing Knowledge Institute (Watt, Straus), St. Michael's Hospital, Toronto, Ont.; Département de médecine familiale (Ewa), University of Calgary; Assisted Living Alberta (Ewa), Calgary, Alb. [email protected].
Read full textPDFDOICite

Related

  1. Efficacy and safety of lecanemab monoclonal antibody in the treatment of mild to moderate Alzheimer’s disease: a systematic review and meta-analysis
    Shang-Ying Li, Jia-Xin Zhang, Long-Zhuan Huang +5
    Frontiers in pharmacologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  2. Progressive Amyloid‐Related Imaging Abnormalities After Discontinuation of Lecanemab in Early Alzheimer Disease in an APOE ε2/ε4 Carrier
    Elisabeth Stögmann, Lukas Haider, Joel Leinkauf +10
    European journal of neurologyPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  3. Liens entre sommeil et maladie d’Alzheimer : impact du sexe féminin
    Géraldine Rauchs, Laura Stankeviciute, Maéva Boulin +2
    Médecine du sommeilPeer-reviewedCC BY-NC 4.0Full textPsychiatry & mental healthHAL
  4. Cost‐effectiveness of lecanemab for early Alzheimer's disease in China
    Xingguang Zhao, Mingsong Xu, Hualin Chen +4
    Alzheimer's & DementiaPeer-reviewedCC BY 4.0Full textGeneral medicinePMC
  5. Sentiment de reconnaissance vis-à-vis d’autrui et maladie d’Alzheimer : à propos d’un cas
    Ingrid Hennebert, Thierry Darnaud, Christine-Vanessa Cuervo-Lombard
    NPG: Neurologie - Psychiatrie - GériatriePeer-reviewedCC BYNeuroscienceGeneral medicineHAL

Cite

BibTeXRIS
BibTeX
@article{weiss2026utilisation,
  title = {{Utilisation du lecanemab au stade précoce de la maladie d’Alzheimer au Canada.}},
  author = {Sophie M Weiss and Jennifer A Watt and Vivian Ewa and Sharon E Straus},
  journal = {CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne},
  year = {2026},
  month = oct,
  doi = {10.1503/cmaj.260193-f},
  url = {https://europepmc.org/article/MED/42833688},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Utilisation du lecanemab au stade précoce de la maladie d’Alzheimer au Canada.
AU  - Sophie M Weiss
AU  - Jennifer A Watt
AU  - Vivian Ewa
AU  - Sharon E Straus
PY  - 2026
DA  - 2026/10/04
JO  - CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
DO  - 10.1503/cmaj.260193-f
UR  - https://europepmc.org/article/MED/42833688
SN  - 0820-3946
SN  - 1488-2329
ER  -